L. Larsson
- Management of Chronic Obstructive Pulmonary DiseaseEdited by N.M. SiafakasBook | Published in 2006DOI: 10.1183/1025448x.erm3806ISBN (electronic): 978-1-904097-82-2
- Diagnosis, Prevention and Treatment of Exercise-Related Asthma, Respiratory and Allergic Disorders in SportsEdited by K-H. Carlsen, L. Delgado and S. Del GiaccoBook | Published in 2005DOI: 10.1183/1025448x.erm3305ISBN (electronic): 978-1-904097-87-7K-H. CarlsenL. Delgado
- Respiratory critical care HERMES: a European core syllabus in respiratory critical care medicineBy A. Artigas, T. Vassilakopoulos, L. Brochard, D. Dellweg, A. Farr, M. Ferrer, J. Geiseler, A. Larsson, S. Nava, P. Navalesi, J-L Noël, S. Orfanos, P. Palange, B. Schoenhofer, A. Simonds and P. PelosiA. ArtigasEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandT. VassilakopoulosEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandL. BrochardEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandD. DellwegEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. FarrEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandM. FerrerEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandJ. GeiselerEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. LarssonEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandS. NavaEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. NavalesiEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandJ-L NoëlEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandS. OrfanosEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. PalangeEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandB. SchoenhoferEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandA. SimondsEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, SwitzerlandP. PelosiEducational Activities, ERS Headquarters 4, Avenue Ste-Luce, CH 1003 Lausanne, Switzerland
- Free, soluble interleukin-17 protein during severe inflammation in human airwaysBy M. Laan, L. Palmberg, K. Larsson and A. LindénM. LaanL. PalmbergK. Larsson
- Exhaled nitric oxide and bronchial responsiveness in healthy subjects exposed to organic dustBy B-;M. Sundblad, B-;M. Larsson, L. Palmberg and K. LarssonB-;M. SundbladB-;M. LarssonL. Palmberg
- The effect of fluticasone on the airway inflammatory response to organic dustBy A. Ek, L. Palmberg and K. LarssonA. EkL. Palmberg
- Saliva is one likely source of leukotriene B4 in exhaled breath condensateBy F. Gaber, F. Acevedo, I. Delin, B-M. Sundblad, L. Palmberg, K. Larsson, M. Kumlin and S-E. DahlénF. GaberF. AcevedoI. DelinB-M. SundbladL. PalmbergK. LarssonM. Kumlin
- Repeated exposure to organic material alters inflammatory and physiological airway responsesBy B-M. Sundblad, I. von Scheele, L. Palmberg, M. Olsson and K. LarssonB-M. SundbladI. von ScheeleL. PalmbergM. Olsson
- Effect of formoterol with or without budesonide in repeated low-dose allergen challengeBy B. Dahlén, A-S. Lantz, E. Ihre, M. Skedinger, E. Henriksson, L. Jörgensen, T. Ekström, S-E. Dahlén and K. LarssonB. DahlénA-S. LantzE. IhreM. SkedingerE. HenrikssonL. JörgensenT. EkströmS-E. Dahlén
- Associated factors with persistent airflow limitation in asthma in U-BIOPREDBy A. Wagener, D. Gibeon, X. Yang, A. Sousa, J. Corfield, D. Shaw, S. Fowler, L. Fleming, J. Riley, L. Jeyasingham, A. Rowe, K. Fichtner, G. Roberts, P. Bakke, F. Singer, T. Geiser, U. Frey, I. Horvarth, R. Polosa, K. Bønnelykke, N. Krug, R. Middelveld, S.-E. Dahlen, B. Dahlen, G. Hedlin, S. Hashimoto, B. Nordlund, J. Musial, A. Woodcock, C. Murray, L. Pahus, P. Chanez, D. Myles, C. Compton, T.W. Higenbottam, P. Montuschi, J. Vestbo, L. Larsson, T. Sandstrom, H. Bisgaard, S.S. Wagers, P.H. Howarth, E.H. Bel, R. Djukanovic, F. Chung and P. SterkA. Wagener2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsD. Gibeon1NHLI, Imperial College London, London, United KingdomX. Yang1NHLI, Imperial College London, London, United KingdomA. Sousa3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomJ. Corfield4Clinical Research, AstraZeneca, Lund, SwedenD. Shaw5Nottingham Respiratory Research Unit, Nottingham City Hospital, Nottingham, United KingdomS. Fowler6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Fleming1NHLI, Imperial College London, London, United KingdomJ. Riley3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomL. Jeyasingham3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomA. Rowe7External Innovation, R&D IT, Janssen Research and Development, London, United KingdomK. Fichtner8Global Clinical Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, United KingdomG. Roberts9Faculty of Medicine, University of Southampton, Southampton, United KingdomP. Bakke10Respiratory Medicine, Haukeland University Hospital, Bergen, NorwayF. Singer11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandT. Geiser11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandU. Frey11Respiratory Medicine, Inselspital and University of Bern, Bern, SwitzerlandI. Horvarth12Department of Pulmonology, Semmelweis University, Budapest, United KingdomR. Polosa13Medicine and Immunology Clinic, University of Catania, Catania, ItalyK. Bønnelykke14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkN. Krug15Medicine, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, GermanyR. Middelveld16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS.-E. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenB. Dahlen16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenG. Hedlin16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenS. Hashimoto2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsB. Nordlund16The Centre for Allergy Research, Karolinska Insitute, Stockholm, SwedenJ. Musial17Medical College, Jagiellonian University, Krakow, PolandA. Woodcock6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomC. Murray6Respiratory Medicine, University of Manchester and Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United KingdomL. Pahus18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceP. Chanez18Hopital Nord, Bureau De Recherche Clinique, Université De La Méditerranee, Marseille, FranceD. Myles3Respiratory Therapy Unit, GlaxoSmithKline, London, United KingdomC. Compton19Horsham Research Center, Novartis Pharma AG, Horsham, United KingdomT.W. Higenbottam20Chiesi Research, Chiesi, London, United KingdomP. Montuschi21Istituto Di Farmacologia, Università Cattolica Del Sacro Cuore, Rome, ItalyJ. Vestbo22Lungemedicinsk Sektion, Hvidovre Hospital, Hvidovre, DenmarkL. Larsson4Clinical Research, AstraZeneca, Lund, SwedenT. Sandstrom23Respiratory and Allergy Division, University Hospital, Umeå, Umeå, SwedenH. Bisgaard14University Hospital, University Hospital, Copenhagen, Copenhagen, DenmarkS.S. Wagers24BioSci Consulting, BioSci Consulting, Maasmechelen, BelgiumP.H. Howarth9Faculty of Medicine, University of Southampton, Southampton, United KingdomE.H. Bel2Academic Medical Centre, University of Amsterdam, Amsterdam, NetherlandsR. Djukanovic9Faculty of Medicine, University of Southampton, Southampton, United KingdomF. Chung1NHLI, Imperial College London, London, United KingdomP. Sterk2Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands
- Saliva is one likely source of leukotriene B<SUB>4</SUB> in exhaled breath condensateBy F. Gaber, F. Acevedo, I. Delin, B-M. Sundblad, L. Palmberg, K. Larsson, M. Kumlin and S-E. DahlénArticle | Published in 2006 in European Respiratory JournalF. GaberF. AcevedoI. DelinB-M. SundbladL. PalmbergK. LarssonM. Kumlin
- Effect of formoterol with or without budesonide in repeated low-dose allergen challengeBy B. Dahlén, A-S. Lantz, E. Ihre, M. Skedinger, E. Henriksson, L. Jörgensen, T. Ekström, S-E. Dahlén and K. LarssonArticle | Published in 2009 in European Respiratory JournalB. DahlénA-S. LantzE. IhreM. SkedingerE. HenrikssonL. JörgensenT. EkströmS-E. Dahlén
- Repeated exposure to organic material alters inflammatory and physiological airway responsesBy B-M. Sundblad, I. von Scheele, L. Palmberg, M. Olsson and K. LarssonArticle | Published in 2009 in European Respiratory JournalB-M. SundbladI. von ScheeleL. PalmbergM. Olsson
- Table 1. –By L. Delgado, K-H. Carlsen and K. LarssonBook | Published in 1970
This is a PDF-only article. The first page of the PDF of this article appears above.
L. DelgadoK-H. Carlsen
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.